MGMT and glioblastoma: Further, low MGMT protein or gene expression is significantly associated with improved patient survival or treatment response independently of MGMT promoter methylation and has also been found to be an independent prognostic marker in glioblastoma patients by multivariate analysis39, 40, 41, 42.